Business Context and Reporting Period
This Form 8-K Current Report was filed by Tivic Health Systems, Inc. on April 22, 2026. The filing announces a corporate name change to Valion Bio, Inc., effective April 28, 2026. The company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Corporate Name: Changed from Tivic Health Systems, Inc. to Valion Bio, Inc.
- Trading Symbol: The ticker symbol will change from 'TIVC' to 'VBIO' on The Nasdaq Capital Market LLC.
- Effective Date: Both the name change and the new ticker symbol are expected to be effective on April 28, 2026.
- Shareholder Rights: The filing states that the name change does not affect the rights of the Company's shareholders and did not require a shareholder vote under Delaware law.
Guidance, Outlook, and Risks
The filing does not contain management commentary regarding financial guidance, future outlook, specific risks, contingencies, or unusual items. The document is limited to the procedural announcement of the name change and the associated filing of the Certificate of Amendment.
Investor Verification Checklist
- Verify the effective date of the ticker symbol change (April 28, 2026) with brokerage platforms to ensure proper trading under 'VBIO'.
- Confirm that existing holdings under 'TIVC' will automatically convert to 'VBIO' without action required by the shareholder.
- Review the attached Certificate of Amendment (Exhibit 3.1) for any additional provisions regarding the name change.
- Check for subsequent press releases or filings that may detail the strategic rationale behind the rebranding to Valion Bio, Inc.